Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 18Completed 16Recruiting 9Not yet recruiting 6Withdrawn 2Terminated 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Gynecologic Surgical Procedures 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Preoperative Exercise × Clear all
NCT04505111 2022-04-11

Prehabilitation Plus ERAS vs ERAS in Gynecological Surgery

Instituto Brasileiro de Controle do Cancer

Phase NA Withdrawn

Gynecologic Surgical Procedures

NCT01919541 2018-03-22

Mechanistic Prehabilitation

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Withdrawn
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡